Global Diabetes Therapy and Drug Delivery Market Size, Status, Research and Forecast 2019-2025

Published On: Aug 2019

Format: PDF

Publisher: QY Research

Pages: 102

Report ID: 51734

In 2018, the global Diabetes Therapy and Drug Delivery market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

This report focuses on the global Diabetes Therapy and Drug Delivery status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Diabetes Therapy and Drug Delivery development in United States, Europe and China.

The key players covered in this study
Abbott Laboratories
Medtronic
Sanofi
Novo Nordisk
MannKind
Enteris BioPharma
Dexcom
Senseonics Holding
Medtech
Johnson & Johnson
Synertech
Zosano Pharma
Relmada Therapeutics
Eli Lilly
Transdermal Specialties

Market segment by Type, the product can be split into
Inhalable Insulin
Oral Insulin
Insulin Patches
CGM Systems
Artificial Pancreas

Market segment by Application, split into
Diagnostic/Clinics
ICUs
Home Healthcare

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Diabetes Therapy and Drug Delivery status, future forecast, growth opportunity, key market and key players.
To present the Diabetes Therapy and Drug Delivery development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Diabetes Therapy and Drug Delivery are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type (2014-2025)
1.4.2 Inhalable Insulin
1.4.3 Oral Insulin
1.4.4 Insulin Patches
1.4.5 CGM Systems
1.4.6 Artificial Pancreas
1.5 Market by Application
1.5.1 Global Diabetes Therapy and Drug Delivery Market Share by Application (2014-2025)
1.5.2 Diagnostic/Clinics
1.5.3 ICUs
1.5.4 Home Healthcare
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Diabetes Therapy and Drug Delivery Market Size
2.2 Diabetes Therapy and Drug Delivery Growth Trends by Regions
2.2.1 Diabetes Therapy and Drug Delivery Market Size by Regions (2014-2025)
2.2.2 Diabetes Therapy and Drug Delivery Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Diabetes Therapy and Drug Delivery Market Size by Manufacturers
3.1.1 Global Diabetes Therapy and Drug Delivery Revenue by Manufacturers (2014-2019)
3.1.2 Global Diabetes Therapy and Drug Delivery Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Diabetes Therapy and Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.2 Diabetes Therapy and Drug Delivery Key Players Head office and Area Served
3.3 Key Players Diabetes Therapy and Drug Delivery Product/Solution/Service
3.4 Date of Enter into Diabetes Therapy and Drug Delivery Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Diabetes Therapy and Drug Delivery Market Size by Type (2014-2019)
4.2 Global Diabetes Therapy and Drug Delivery Market Size by Application (2014-2019)

5 United States
5.1 United States Diabetes Therapy and Drug Delivery Market Size (2014-2019)
5.2 Diabetes Therapy and Drug Delivery Key Players in United States
5.3 United States Diabetes Therapy and Drug Delivery Market Size by Type
5.4 United States Diabetes Therapy and Drug Delivery Market Size by Application

6 Europe
6.1 Europe Diabetes Therapy and Drug Delivery Market Size (2014-2019)
6.2 Diabetes Therapy and Drug Delivery Key Players in Europe
6.3 Europe Diabetes Therapy and Drug Delivery Market Size by Type
6.4 Europe Diabetes Therapy and Drug Delivery Market Size by Application

7 China
7.1 China Diabetes Therapy and Drug Delivery Market Size (2014-2019)
7.2 Diabetes Therapy and Drug Delivery Key Players in China
7.3 China Diabetes Therapy and Drug Delivery Market Size by Type
7.4 China Diabetes Therapy and Drug Delivery Market Size by Application

8 Japan
8.1 Japan Diabetes Therapy and Drug Delivery Market Size (2014-2019)
8.2 Diabetes Therapy and Drug Delivery Key Players in Japan
8.3 Japan Diabetes Therapy and Drug Delivery Market Size by Type
8.4 Japan Diabetes Therapy and Drug Delivery Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Diabetes Therapy and Drug Delivery Market Size (2014-2019)
9.2 Diabetes Therapy and Drug Delivery Key Players in Southeast Asia
9.3 Southeast Asia Diabetes Therapy and Drug Delivery Market Size by Type
9.4 Southeast Asia Diabetes Therapy and Drug Delivery Market Size by Application

10 India
10.1 India Diabetes Therapy and Drug Delivery Market Size (2014-2019)
10.2 Diabetes Therapy and Drug Delivery Key Players in India
10.3 India Diabetes Therapy and Drug Delivery Market Size by Type
10.4 India Diabetes Therapy and Drug Delivery Market Size by Application

11 Central & South America
11.1 Central & South America Diabetes Therapy and Drug Delivery Market Size (2014-2019)
11.2 Diabetes Therapy and Drug Delivery Key Players in Central & South America
11.3 Central & South America Diabetes Therapy and Drug Delivery Market Size by Type
11.4 Central & South America Diabetes Therapy and Drug Delivery Market Size by Application

12 International Players Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Diabetes Therapy and Drug Delivery Introduction
12.1.4 Abbott Laboratories Revenue in Diabetes Therapy and Drug Delivery Business (2014-2019)
12.1.5 Abbott Laboratories Recent Development
12.2 Medtronic
12.2.1 Medtronic Company Details
12.2.2 Company Description and Business Overview
12.2.3 Diabetes Therapy and Drug Delivery Introduction
12.2.4 Medtronic Revenue in Diabetes Therapy and Drug Delivery Business (2014-2019)
12.2.5 Medtronic Recent Development
12.3 Sanofi
12.3.1 Sanofi Company Details
12.3.2 Company Description and Business Overview
12.3.3 Diabetes Therapy and Drug Delivery Introduction
12.3.4 Sanofi Revenue in Diabetes Therapy and Drug Delivery Business (2014-2019)
12.3.5 Sanofi Recent Development
12.4 Novo Nordisk
12.4.1 Novo Nordisk Company Details
12.4.2 Company Description and Business Overview
12.4.3 Diabetes Therapy and Drug Delivery Introduction
12.4.4 Novo Nordisk Revenue in Diabetes Therapy and Drug Delivery Business (2014-2019)
12.4.5 Novo Nordisk Recent Development
12.5 MannKind
12.5.1 MannKind Company Details
12.5.2 Company Description and Business Overview
12.5.3 Diabetes Therapy and Drug Delivery Introduction
12.5.4 MannKind Revenue in Diabetes Therapy and Drug Delivery Business (2014-2019)
12.5.5 MannKind Recent Development
12.6 Enteris BioPharma
12.6.1 Enteris BioPharma Company Details
12.6.2 Company Description and Business Overview
12.6.3 Diabetes Therapy and Drug Delivery Introduction
12.6.4 Enteris BioPharma Revenue in Diabetes Therapy and Drug Delivery Business (2014-2019)
12.6.5 Enteris BioPharma Recent Development
12.7 Dexcom
12.7.1 Dexcom Company Details
12.7.2 Company Description and Business Overview
12.7.3 Diabetes Therapy and Drug Delivery Introduction
12.7.4 Dexcom Revenue in Diabetes Therapy and Drug Delivery Business (2014-2019)
12.7.5 Dexcom Recent Development
12.8 Senseonics Holding
12.8.1 Senseonics Holding Company Details
12.8.2 Company Description and Business Overview
12.8.3 Diabetes Therapy and Drug Delivery Introduction
12.8.4 Senseonics Holding Revenue in Diabetes Therapy and Drug Delivery Business (2014-2019)
12.8.5 Senseonics Holding Recent Development
12.9 Medtech
12.9.1 Medtech Company Details
12.9.2 Company Description and Business Overview
12.9.3 Diabetes Therapy and Drug Delivery Introduction
12.9.4 Medtech Revenue in Diabetes Therapy and Drug Delivery Business (2014-2019)
12.9.5 Medtech Recent Development
12.10 Johnson & Johnson
12.10.1 Johnson & Johnson Company Details
12.10.2 Company Description and Business Overview
12.10.3 Diabetes Therapy and Drug Delivery Introduction
12.10.4 Johnson & Johnson Revenue in Diabetes Therapy and Drug Delivery Business (2014-2019)
12.10.5 Johnson & Johnson Recent Development
12.11 Synertech
12.12 Zosano Pharma
12.13 Relmada Therapeutics
12.14 Eli Lilly
12.15 Transdermal Specialties

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details